Health Care Industry Research & Analysis

Bookmark and Share

Long Term Stock Rating

Technical Analysis / Charts

Investor Survey (help)

SWOT Strengths > SWOT Weaknesses?
-----
SWOT Opportunities > SWOT Threats?

Health Care ETF Funds

Leveraged ETF Funds

2x S&P Health Care ETF (RHM)
Inverse 2x S&P Health Care ETF (RHO)

US ETF Funds

First Trust Health Care (FXH)
iShares Health Care ETF (IYH)
Health Care Providers ETF (IHF)
ProShares Health Care (RXL)
Short Health Care (RXD)
S&P Equal Weight Health Care ETF (RYH)
SPDR Health Care (XLV)
Vanguard Health Care ETF (VHT)

Non - US ETF Funds

Emerging Healthcare (EHK)
iShares Healthcare (IXJ)
S&P Intl Health Care ETF (IRY)
Intl Health Care (DBR)
Cancer ETF (HHK)
Cardiology ETF (HRD)
Enabling Technologies ETF (HHV)
European Drugs (HRJ)

Index of Health Care Companies

3SBio (SSRX) Investment Research
ABAXIS (ABAX) Investment Research
Abbott Labs (ABT) Investment Research
ABID (ABMD) Investment Research
Accuray (ARAY) Investment Research
Aceto (ACET) Investment Research
Acorda Therapeutics (ACOR) Investment Research
Acura Pharma (ACUR) Investment Research
Advisory Board (ABCO) Investment Research
Advocat (AVCA) Investment Research
Aetna (AET) Investment Research
Affymax (AFFY) Investment Research
Akorn (AKRX) Investment Research
Albany Molecular Research (AMRI) Investment Research
Alcon (ACL) Investment Research
Alexza Pharma (ALXA) Investment Research
Align Technology (ALGN) Investment Research
Alkermes (ALKS) Investment Research
Allergan (AGN) Investment Research
Alliance Imaging (AIQ) Investment Research
Allied HealthCare (AHCI) Investment Research
Allied Healthcare (AHPI) Investment Research
Almost Family (AFAM) Investment Research
Alphatec (ATEC) Investment Research
Amedisys (AMED) Investment Research
American Caresource (ANCI) Investment Research
American Dental Partners (ADPI) Investment Research
American Medical (AMMD) Investment Research
American Oriental Bioeng (AOB) Investment Research
AMERIGROUP (AGP) Investment Research
AmerisourceBergen (ABC) Investment Research
Amgen (AMGN) Investment Research
Amicus Therapeutics (FOLD) Investment Research
AMN Healthcare (AHS) Investment Research
Amsurg (AMSG) Investment Research
Amylin Pharma (AMLN) Investment Research
AngioDynamics (ANGO) Investment Research
Applera (ABI) Investment Research
Ardea Biosciences (RDEA) Investment Research
ArQule (ARQL) Investment Research
Array BioPharma (ARRY) Investment Research
AspenBio Pharma (APPY) Investment Research
Assisted Living Concepts (ALC) Investment Research
Astrazeneca (AZN) Investment Research
ATRION Corp (ATRI) Investment Research
ATS Medical (ATSI) Investment Research
Barr Pharma (BRL) Investment Research
Baxter Intl (BAX) Investment Research
Becton Dickinson (BDX) Investment Research
Bioanalytical Systems (BASI) Investment Research
Biodel (BIOD) Investment Research
Biogen IDEC (BIIB) Investment Research
Bio-Imaging Tech (BITI) Investment Research
BioMimetic Therapeutics (BMTI) Investment Research
Bio-Reference Labs (BRLI) Investment Research
Biosante Pharma (BPAX) Investment Research
BioScrip (BIOS) Investment Research
BioSphere Medical (BSMD) Investment Research
Biovail (BVF) Investment Research
BMP Sunstone (BJGP) Investment Research
Boston Scientific (BSX) Investment Research
Bristol-Myers Squibb (BMY) Investment Research
Brookdale Senior Living (BKD) Investment Research
Cambrex (CBM) Investment Research
Cantel Medical (CMN) Investment Research
Capital Senior Living (CSU) Investment Research
Cardiac Science (CSCX) Investment Research
Cardinal Health (CAH) Investment Research
CardioNet (BEAT) Investment Research
CAS Medical Sys (CASM) Investment Research
Celgene (CELG) Investment Research
Centene (CNC) Investment Research
Cephalon (CEPH) Investment Research
Charles River Labs (CRL) Investment Research
Chattem (CHTT) Investment Research
Chelsea Therapeutics (CHTP) Investment Research
Chemed (CHE) Investment Research
China Medical Tech (CMED) Investment Research
China Sky One Medical (CSKI) Investment Research
China-Biotics (CHBT) Investment Research
Chindex Intl (CHDX) Investment Research
CIGNA (CI) Investment Research
Clinical Data (CLDA) Investment Research
CombiMatrix (CBMX) Investment Research
Community Health Sys (CYH) Investment Research
Conceptus (CPTS) Investment Research
CONMED (CNMD) Investment Research
Cooper Companies (COO) Investment Research
Covance (CVD) Investment Research
Coventry (CVH) Investment Research
Covidien (COV) Investment Research
CPEX Pharma (CPEX) Investment Research
CR Bard (BCR) Investment Research
Cross Country Healthcare (CCRN) Investment Research
Crucell (CRXL) Investment Research
CryoLife (CRY) Investment Research
Cubist Pharma (CBST) Investment Research
Cutera (CUTR) Investment Research
Cyberonics (CYBX) Investment Research
Cytokinetics (CYTK) Investment Research
Cytori Therapeutics (CYTX) Investment Research
Datascope (DSCP) Investment Research
DaVita (DVA) Investment Research
Dendreon (DNDN) Investment Research
DENTSPLY (XRAY) Investment Research
Discovery Labs (DSCO) Investment Research
Dr. Reddy's Labs (RDY) Investment Research
Durect (DRRX) Investment Research
Dyax (DYAX) Investment Research
Dynacq Healthcare (DYII) Investment Research
Edwards Lifesciences (EW) Investment Research
Elan Corp (ELN) Investment Research
Eli Lilly (LLY) Investment Research
Emergent Biosolutions (EBS) Investment Research
Emeritus (ESC) Investment Research
Endo Pharma (ENDP) Investment Research
Ensign (ENSG) Investment Research
Enzo Biochem (ENZ) Investment Research
Enzon Pharmaceuticals (ENZN) Investment Research
eResearch Tech (ERES) Investment Research
Escalon Medical (ESMC) Investment Research
Eurand (EURX) Investment Research
ev3 (EVVV) Investment Research
Exactech (EXAC) Investment Research
Exelixis (EXEL) Investment Research
Express Scripts (ESRX) Investment Research
FGX (FGXI) Investment Research
Forest Labs (FRX) Investment Research
Fresenius Medical Care (FMS) Investment Research
Genentech (DNA) Investment Research
Genoptix (GXDX) Investment Research
Gentiva (GTIV) Investment Research
Genzyme (GENZ) Investment Research
Geron Corp (GERN) Investment Research
Gilead Sciences (GILD) Investment Research
Given Imaging (GIVN) Investment Research
GlaxoSmithKline (GSK) Investment Research
Greatbatch (GB) Investment Research
GTx (GTXI) Investment Research
Haemonetics (HAE) Investment Research
Hanger Orthopedic (HGR) Investment Research
Hansen Medical (HNSN) Investment Research
Health Management (HMA) Investment Research
Health Net (HNT) Investment Research
Healthcare Services (HCSG) Investment Research
HealthSouth Corp (HLS) Investment Research
Healthspring (HS) Investment Research
Healthways (HWAY) Investment Research
Henry Schein (HSIC) Investment Research
Hillenbrand Industries (HRC) Investment Research
Hologic (HOLX) Investment Research
Hospira (HSP) Investment Research
Humana (HUM) Investment Research
ICON (ICLR) Investment Research
ICU Medical (ICUI) Investment Research
Idenix Pharma (IDIX) Investment Research
Idera Pharma (IDRA) Investment Research
IDEXX Labs (IDXX) Investment Research
I-Flow Corp (IFLO) Investment Research
Illumina (ILMN) Investment Research
Immucor (BLUD) Investment Research
ImmunoGen (IMGN) Investment Research
IMS Health (RX) Investment Research
Incyte Corp (INCY) Investment Research
Indevus Pharma (IDEV) Investment Research
Infinity Pharma (INFI) Investment Research
Insulet Corp (PODD) Investment Research
Integra LifeSciences (IART) Investment Research
IntegraMed America (INMD) Investment Research
InterMune (ITMN) Investment Research
Intuitive Surgical (ISRG) Investment Research
Invacare Corp (IVC) Investment Research
inVentiv Health (VTIV) Investment Research
IPC The Hospitalist (IPCM) Investment Research
Johnson & Johnson (JNJ) Investment Research
Kendle (KNDL) Investment Research
Kensey Nash (KNSY) Investment Research
Kindred Healthcare (KND) Investment Research
Kinetic Concepts (KCI) Investment Research
King Pharma (KG) Investment Research
Laboratory of America (LH) Investment Research
Lare (LNCR) Investment Research
LeMaitre Vascular (LMAT) Investment Research
LHC Group (LHCG) Investment Research
Life Tech (LIFE) Investment Research
LifePoint Hospitals (LPNT) Investment Research
Ligand Pharma (LGND) Investment Research
Luminex (LMNX) Investment Research
Magellan Health (MGLN) Investment Research
MAKO Surgical (MAKO) Investment Research
MannKind Corp (MNKD) Investment Research
MAP Pharma (MAPP) Investment Research
Martek Biosciences (MATK) Investment Research
Masimo (MASI) Investment Research
Matrixx Initiatives (MTXX) Investment Research
Maxygen (MAXY) Investment Research
McKesson (MCK) Investment Research
Medarex (MEDX) Investment Research
MedCath (MDTH) Investment Research
Medco Health (MHS) Investment Research
Medical Action (MDCI) Investment Research
Medicines (MDCO) Investment Research
Medicis Pharmaceutical (MRX) Investment Research
Medivation (MDVN) Investment Research
Medtox Scientific (MTOX) Investment Research
Medtronic (MDT) Investment Research
Mentor Intl (MNT) Investment Research
Merck (MRK) Investment Research
Meridian Bioscience (VIVO) Investment Research
Merit Medical (MMSI) Investment Research
Metabolix (MBLX) Investment Research
Micromet (MITI) Investment Research
Micrus Endovascular (MEND) Investment Research
MiddleBrook Pharma (MBRK) Investment Research
Millipore (MIL) Investment Research
Mindray Medical Intl (MR) Investment Research
Mine Safety Appliances (MSA) Investment Research
Molecular Insight Pharma (MIPI) Investment Research
Molina Healthcare (MOH) Investment Research
MWI Veterinary Supply (MWIV) Investment Research
Mylan Laboratories (MYL) Investment Research
Myriad Genetics (MYGN) Investment Research
Nabi Biopharma (NABI) Investment Research
Nanosphere (NSPH) Investment Research
Natus Medical (BABY) Investment Research
NBTY (NTY) Investment Research
Nektar Therapeutics (NKTR) Investment Research
Neogen (NEOG) Investment Research
Neurocrine Biosciences (NBIX) Investment Research
NightHawk Radiology (NHWK) Investment Research
Novartis (NVS) Investment Research
Noven Pharma (NOVN) Investment Research
Novo Nordisk (NVO) Investment Research
NuVasive (NUVA) Investment Research
NxStage Medical (NXTM) Investment Research
Obagi Medical Products (OMPI) Investment Research
Odyssey Healthcare (ODSY) Investment Research
OraSure Tech (OSUR) Investment Research
Orexigen Therapeutics (OREX) Investment Research
Orthofix Intl (OFIX) Investment Research
Orthovita (VITA) Investment Research
OSI Pharma (OSIP) Investment Research
Osteotech (OSTE) Investment Research
Owens & Minor (OMI) Investment Research
Pain Therapeutics (PTIE) Investment Research
Palomar Medical Tech (PMTI) Investment Research
PAREXEL (PRXL) Investment Research
Patterson (PDCO) Investment Research
PDL BioPharma (PDLI) Investment Research
PerkinElmer (PKI) Investment Research
Perrigo (PRGO) Investment Research
PetMed Express (PETS) Investment Research
Pfizer (PFE) Investment Research
Pharma Product Development (PPDI) Investment Research
Pharma Resources (PRX) Investment Research
PharmaNet Development (PDGI) Investment Research
Pharmasset (VRUS) Investment Research
Phase Forward (PFWD) Investment Research
Pozen (POZN) Investment Research
Prestige Brand (PBH) Investment Research
PSS World Medical (PSSI) Investment Research
Psychemedics (PMD) Investment Research
Psychiatric Solutions (PSYS) Investment Research
Qiagen (QGEN) Investment Research
QLT (QLTI) Investment Research
Quest Diagnostics (DGX) Investment Research
Questcor Pharma (QCOR) Investment Research
Quidel (QDEL) Investment Research
RadNet (RDNT) Investment Research
Regeneron Pharma (REGN) Investment Research
Rehabcare Group (RHB) Investment Research
Repligen Corp (RGEN) Investment Research
Repros Therapeutics (RPRX) Investment Research
Res-Care (RSCR) Investment Research
ResMed (RMD) Investment Research
Response Genetics (RGDX) Investment Research
Rochester Medical (ROCM) Investment Research
RTI Biologics (RTIX) Investment Research
Salix Pharma (SLXP) Investment Research
Sangamo BioSciences (SGMO) Investment Research
Sanofi-Aventis (SNY) Investment Research
Schering-Plough (SGP) Investment Research
SciClone Pharma (SCLN) Investment Research
Seattle Genetics (SGEN) Investment Research
Sepracor (SEPR) Investment Research
Sequenom (SQNM) Investment Research
Shire (SHPGY) Investment Research
SIGA Technologies (SIGA) Investment Research
Sirona Dental Sys (SIRO) Investment Research
Skilled Healthcare (SKH) Investment Research
Smith & Nephew (SNN) Investment Research
Somanetics (SMTS) Investment Research
SonoSite (SONO) Investment Research
Span-America Medical (SPAN) Investment Research
Spectranetics (SPNC) Investment Research
Spectrum Pharma (SPPI) Investment Research
St Jude Medical (STJ) Investment Research
StemCells (STEM) Investment Research
Stereotaxis (STXS) Investment Research
STERIS (STE) Investment Research
Stryker (SYK) Investment Research
Sucampo Pharma (SCMP) Investment Research
Sun Healthcare (SUNH) Investment Research
SuperGen (SUPG) Investment Research
SurModics (SRDX) Investment Research
Symmetry Medical (SMA) Investment Research
Symyx Tech (SMMX) Investment Research
Syneron Medical (ELOS) Investment Research
Synovis Life Tech (SYNO) Investment Research
Synta Pharma (SNTA) Investment Research
Techne (TECH) Investment Research
Tenet Healthcare (THC) Investment Research
Teva Pharma (TEVA) Investment Research
Theravance (THRX) Investment Research
Thermo Fisher Scientific (TMO) Investment Research
Thoratec (THOR) Investment Research
TomoTherapy (TOMO) Investment Research
TranS1 (TSON) Investment Research
U.S. Physical Therapy (USPH) Investment Research
United Health (UNH) Investment Research
United Therapeutics (UTHR) Investment Research
Universal American (UAM) Investment Research
Universal Health Services (UHS) Investment Research
USANA Health Sciences (USNA) Investment Research
Utah Medical Products (UTMD) Investment Research
Valeant Pharma (VRX) Investment Research
Varian Medical (VAR) Investment Research
Vascular Solutions (VASC) Investment Research
VCA Antech (WOOF) Investment Research
Vertex Pharmaceuticals (VRTX) Investment Research
ViroPharma (VPHM) Investment Research
Virtual Radiologic (VRAD) Investment Research
Vivus (VVUS) Investment Research
VNUS Medical Tech (VNUS) Investment Research
Volcano (VOLC) Investment Research
Warner Chilcott (WCRX) Investment Research
Waters Corp (WAT) Investment Research
Watson Pharma (WPI) Investment Research
Wellcare Group (WCG) Investment Research
WellPoint (WLP) Investment Research
West Pharma (WST) Investment Research
World Heart Corp (WHRT) Investment Research
Wright Medical (WMGI) Investment Research
Wuxi Pharmatech (WX) Investment Research
Wyeth (WYE) Investment Research
XenoPort (XNPT) Investment Research
Young Innovations (YDNT) Investment Research
Zimmer (ZMH) Investment Research
Zoll Medical (ZOLL) Investment Research

Health Care Industry Research Report

Industry Business Cycle Chart
Home Page
1. Staples
2. Discretionary
3. Health Care
4. Financial
5. Telecom
6. Industrial (basic)
7. Industrial (adv)
8. Technology
9. Energy
10. Utility
11. Material
Health Care Industry Buy, Sell, Hold Indicator

Health Care Industry Research & Analysis (edit / improve) The health care industry depends on the care of health-related services by professionals for the benefit of patients. Medical device markers, insurance companies, pharmaceutical drug developers and government institutions are major participants in the treatment of sick, injured and disabled patients. Health Care Value Investing Conclusion Based on WikiWealth's Wall Street analysis, this industry is a Buy, but with good potential for short term growth. The Main Street analysis says a Hold, with SWOT strengths much great than weaknesses and SWOT opportunities less than threats. Major threats include government regulation and reimbursement policy inconsistency. Health Care Trade Hubs: Some of the main medical hubs include Switzerland, USA, and Japan, while the main health care commodities include advanced plastics, opium and cannabis. Health Care Trading Strategy: Health Care stocks tend to be less sensitive to economic changes. Look for undervalued health care investments at any point in the business cycle when stock prices are low. However, biotech, employment staffing and insurance companies may all decrease during recessions for different reasons. Government intervention is another important factor in health care investments, since government spending in health care is a very large portion of overall health care spending. When governments change spending plans, different sub-sectors in the industry are significantly affected. Upward sloping stock charts and financial news may indicate a selling opportunity while the opposite means that stocks are becoming undervalued. For our entire list of industry research reports, including trends, statistics and ratios, click here: Industry Research & Analysis Home Page.

Investment Impacts (help)

Switzerland Country Flag Image & Analysis

Switzerland Country & Currency Research Report (edit / improve) Switzerland (CHF) has a highly productive, capitalist economy with political and economic stability. Switzerland's Fundamental Currency Analysis (short term investment): Switzerland’s currency is overvalued according to the investment flow analysis, purchase price parity, and interest rate parity. Switzerland's Value Investor Survey (short term investment): Switzerland’s economic environment is very favorable for long term economic growth due to high scores on economic freedom, government stability, and significant strengths. Switzerland's General Trading Partners: France, Germany, the USA, and Italy are the top export partners, while the leading industry is financial services. Switzerland's Commodity Trading Partners: Switzerland does not have significant exports, besides energy. SWOT Analysis of Switzerland: The leading Swiss strength is their traditionally political neutrality, while the main weakness is the long expectancy of their citizens, who could burden the fiscal position of the country. Switzerland's Currency Trading Strategy: An overvalued currency, low investment flow potential, but favorable business environment leads to a neutral outlook for Swiss investments. For our entire list of country & currency analysis, see the Country & Currency Analysis home page.

USA Country Flag Image & Analysis

USA Country & Currency Research Report (edit / improve) The United States (US) has a highly productive, capitalist economy and is the largest and most diverse market in the world. USA's Fundamental Currency Analysis (short term investment): the US dollar (USD) has the potential to increase in value especially versus the Australian and Canadian dollar because of the significant potential of undervalued companies. USA's Value Investor Survey (short term investment): the economic environment is very favorable for long term economic growth due to high scores on economic freedom and economic diversity. USA's General Trading Partners: China, Japan, Mexico, and Canada are the top US trading partners, while the leading export and import are electrical machinery and vehicles, respectively. USA's Commodity Trading Partners: The US produces a significant amount of coal and wheat for use at home and as an export. However, the US consumes a larger amount of oil, which contributes to their trade deficit. SWOT Analysis of USA: The leading US strength is its entrepreneurial culture, while the main weakness is high health care cost. Energy independence has the opportunity to propel growth, while the major threat is the housing crisis, which will lower growth. USA's Currency Trading Strategy: An undervalued currency, high investment flow potential and favorable business environment lead to a positive outlook for US investments, which will also benefit from positive international actions. For our entire list of country & currency analysis, see the Country & Currency Analysis home page.

Japan Country Flag Image & Analysis

Japan Country & Currency Research Report (edit / improve) Japan (JPY), the second largest economy in the world, has an industrial, export oriented economy that benefits from its relationship with the USA and proximity to China. Japan's Fundamental Currency Analysis (short term investment): Japan’s currency (the Yen) is overvalued according to investment flow potential, the purchase price parity, and the interest rate parity. Japan's Value Investor Survey (short term investment): Japan’s economic environment is moderately favorable for long term economic growth due to high scores on economic freedom and government transparency, but low scores on the SWOT Analysis. Japan's General Trading Partners: Indonesia, China, Singapore, the EU, Korea, and the US are Japan’s top export partners, while the leading industry is industrial manufacturing. Japan's Commodity Trading Partners: Japan imports many products because of its lack of arable land and energy resources. SWOT Analysis of Japan: The leading Japanese strength is their education system, while the main weakness is a declining birth rate. A major Japanese threat is the continuation of zombie companies. Japan's Currency Trading Strategy: An overvalued currency, low investment flow potential and moderate business environment leads to a negative outlook for Japanese investments. For our entire list of country & currency analysis, see the Country & Currency Analysis home page.

Commodity Investment Impact

Plastic Commodity Research & Analysis Image

Plastic Commodity Research & Analysis Report (edit / improve) Plastic is a synthetic material that has a wide area of uses in the industrial and manufacturing industries. Plastic Fundamental Commodity Analysis (short term investment): Plastic is rated a Hold. Plastic demanders and suppliers have average potential to increase in value. Plastic Value Investor Survey (long term investment): Plastic’s long term growth potential is moderately unfavorable due to low scores in short supply and substitute products. Plastic SWOT Analysis: The SWOT analysis for plastic is incomplete. Plastic Trade Analysis: The commodity analysis hold rating indicates that plastic should stay the same price over the short term, whereas a moderately favorable investor survey means plastic may decrease in price over the long term. For our entire list of commodities, see the Commodity Research & Analysis home page.

- Health care uses a variety of very high quality plastics to build instruments and devices.

Opium Commodity Research & Analysis Image

Opium Commodity Research & Analysis Report (edit / improve) Opium is a narcotic derived from opium pods. It contains morphine and codeine and is highly addictive. Opium Fundamental Commodity Analysis (short term investment): Opium is rated a Buy, because demanders of the plant have a high potential to increase in value. Unfortunately from an analytical standpoint, there are no publicly traded suppliers of opium; therefore, this analysis is incomplete. Opium Value Investor Survey (long term investment): Opium’s long term growth potential is moderately favorable due to high scores on sensitivity to price changes. Opium SWOT Analysis: Strength: Opium has a number of medical uses; Weakness: The drug known as heroin is derived from the production of opium. Opportunity to grow: Opium’s medical uses are growing. This should increase demand for opium. Threat to grow: opium, in a concentrated form, is illegal through the world. Opium Trade Analysis: The commodity analysis buy rating indicates that opium should increase in price over the short term, whereas a moderately favorable investor survey means opium may increase in price over the long term. For our entire list of commodities, see the Commodity Research & Analysis home page.

- Opium derivative products are major, but addictive, sources of treatment of patients.

Cannabis Commodity Research & Analysis Image

Cannabis Commodity Research & Analysis Report (edit / improve) Cannabis (also known as marijuana, ganja, weed, pot… etc) is mainly used as a recreational drug because of its psychoactive chemical compounds. Cannabis Fundamental Commodity Analysis (short term investment): Cannabis is rated a Buy, because demanders of the drug have a high potential to increase in value. Unfortunately from an analytical standpoint, there are no publicly traded suppliers of cannabis; therefore, this analysis is incomplete. Cannabis Value Investor Survey (long term investment): Cannabis’s long term growth potential is moderately favorable due to high scores on sensitivity to price changes. Cannabis SWOT Analysis: Strength: Cannabis has a number of medical uses; Weakness: The sale of cannabis produces considerable corruption and violence. Opportunity to grow: decriminalization of cannabis could provide an economic boost to local economies and increase the demand for cannabis. Cannabis Trade Analysis: The commodity analysis buy rating indicates that cannabis should increase in price over the short term, whereas a moderately favorable investor survey means cannabis may increase in price over the long term. For our entire list of commodities, see the Commodity Research & Analysis home page.

- Cannabis is becoming a mainstream drug for the alleviation of some cancer treatment side effects.